Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the ...

Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating ...

I reiterate a 'Buy' rating for ASML with a one-year target price of US$864 per share, driven by AI's continued growth.

As services become a bigger part of Apple’s business, the company continues to deliver higher profit margins for investors.

Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.

CEO Ned Handy announced the completion of a significant $70.5 million capital raise in December, aimed at repositioning the balance sheet by selling lower-yielding assets and reinvesting in ...

Daiwa analyst Jairam Nathan has maintained their neutral stance on TSLA stock, giving a Hold rating today.Invest with Confidence: Follow ...

Bank of America Securities analyst John Murphy has reiterated their neutral stance on TSLA stock, giving a Hold rating today.Invest with ...

AB B (LON:0HBP) tumbled 5.75% as the retailer reported fourth-quarter sales on Thursday that fell short of expectations and issued a cautious margin outlook.

NeuroPace Expects FY25 Revenue Of $92M – $96M (Est $91.239M), Gross Margin Of 73% – 75% Littelfuse Expects Q1 FY25 Net Sales Of $520M - $550M (Est $540.992M), Adjusted EPS Of $1.70 - $1.90 ...